Nurse Practitioner, Adult Health · Milwaukee, WI
NPI
1740423441
Since 2009
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5300 W Villard Ave
Milwaukee, WI, 53218
Phone (414) 438-6666
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
325 services
Medicare patients, 2024
37
Average age 62
Drug cost, 2024
$706K
8,012 prescriptions
Company payments, 2025
$3,755
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anatoliy Velikodanov was code 99213 (office e&m - established), 104 times for 26 patients. In total Anatoliy Velikodanov billed 325 services in 17 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 104 | 26 | $48.10 | $5,002 |
| 99214 Office E&M - Established | Office | 71 | 26 | $68.36 | $4,854 |
| 83036 Blood Count | Office | 26 | 19 | $9.52 | $248 |
| 81002 Clinical Chemistry | Office | 18 | 14 | $3.41 | $61.38 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 11 | 11 | $103.48 | $1,138 |
By year: 2022 $28K for 512 services; 2023 $11K for 208 services; 2024 $12K for 325 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 26 | 19 | $9.52 | $248 |
| 81002 Clinical Chemistry | 18 | 14 | $3.41 | $61.38 |
Medicare prescription drug claims, 2024
In 2024, the drug Anatoliy Velikodanov prescribed most often to Medicare patients was Atorvastatin Calcium, with 588 prescriptions and refills. In total Anatoliy Velikodanov wrote 8,012 Medicare prescriptions that cost $706K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 588 | 1,266 | 155 | $4,305 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 499 | 557 | 101 | $13K |
| Amlodipine Besylate Generic | 396 | 912 | 110 | $2,232 |
| Losartan Potassium Generic | 289 | 658 | 76 | $1,932 |
| Potassium Chloride Generic | 187 | 311 | 50 | $1,615 |
| Metformin Hcl Generic | 186 | 435 | 57 | $882 |
| Furosemide Generic | 174 | 303 | 42 | $871 |
| Tramadol Hcl Generic | 159 | 159 | 22 | $1,234 |
| Omeprazole Generic | 159 | 309 | 55 | $2,532 |
| Metoprolol Succinate Generic | 157 | 347 | 43 | $1,034 |
| Hydrochlorothiazide Generic | 157 | 388 | 52 | $848 |
| Fluticasone Propionate Generic | 139 | 194 | 40 | $1,833 |
| Lisinopril Generic | 138 | 310 | 40 | $885 |
| Gabapentin Generic | 118 | 137 | 22 | $1,162 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 115 | 251 | 30 | $489 |
Brand drugs: 1,325 claims; generic drugs: 6,579 claims; opioid claims: 315.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anatoliy Velikodanov $3,755 ($3,755 in general payments such as food, travel and fees) from 26 companies. The largest payer was Pfizer Inc. with $453.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 26 | $453 |
| Abbvie Inc. ABBV | 24 | $427 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 16 | $326 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $310 |
| Novo Nordisk Inc NVO | 14 | $258 |
| Lilly USA, LLC LLY | 13 | $238 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 12 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 11 | $184 |
| Aimmune Therapeutics, Inc. | 10 | $163 |
| Axsome Therapeutics, Inc. AXSM | 14 | $163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.